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Summary Intracardiac injection, in hooded Lister rats, of syngeneic MC28 sarcoma cells never induced
tumour growth in normal bowel. Tumour growth occurred at the site of a colonic anastomosis if surgery
preceded tumour injection but not if it followed tumour injection, even by as little as 1h. Maximum
enhancement of tumour growth occurred when the healing process had progressed between 2 and 8 days, with
a peak at 5 to 7 days. The enhancing effect was largely over by the time the healing had progressed 14 days.
The syngeneic OES5 breast carcinoma also grew at colonic anastomoses when surgery preceded tumour
injection by 5 days, but not in normal colon. The MC28 sarcoma also grew at ileal anastomoses but not in
the normal ileum after intracardiac injection. By injecting radiolabelled sarcoma cells, an estimate of the
probability of a single bloodborne tumour cell lodging at a colonic anastomosis and leading to a tumour
deposit was calculated to be of the order of 1:43 whereas the probability of the cell lodging in normal colon
and causing a deposit is < 1:4 x 104.
When cells from the transplantable syngeneic sarcoma and
carcinoma used in this study are injected into the left
ventricle of a rat, they distribute to all organs in proportion
to the fraction of the cardiac output they receive (Murphy et
al., 1986). However, some organs (e.g., adrenals and bone),
commonly develop deposits, other organs (e.g., skin and
lungs), occasionally develop deposits, whilst others (e.g.,
spleen and intestines), never develop deposits. This effect is
reproducible with different tumours and appears to be a
feature of the behaviour of the recipient tissue rather than
the tumour (Murphy et al., 1986). The resistance of the
colon to growth of these experimental tumours is paralleled
by the clinical observation that the large bowel is a rare site
for bloodborne secondary deposits from primary malignan-
cies elsewhere in the body.
Trauma to a tissue is known to enhance the ability of that
tissue to support growth of tumour either from locally
implanted cells (Jones & Rous, 1914), or from cells that
reached the site of injury via the circulation (Robinson &
Hoppe, 1962; Alexander & Altemeier, 1964; Fisher & Fisher,
1965).
Following intracardiac injection of the two tumours used
in this investigation, Murphy et al. (1988) found that growth
occurred much more readily in healing laparotomy wounds
than in the surrounding normal skeletal muscle. There have
been no studies to investigate the effect of surgical trauma
on the ability of the large bowel to support growth of
tumour cells delivered by the circulation. The aims of this
investigation were firstly to determine whether surgical
trauma to the colon would enhance its ability to support
growth of bloodborne cancer cells; and secondly, if enhance-
ment did take place, to determine at which stage in the
healing process the enhancement is at a maximum.
Materials and methods
Animals
These were syngeneic hooded Lister rats, obtained initially
from the Chester Beatty Institute and then maintained as an
inbred line in Southampton. Both males (weight 200-300g)
and females (weight 150-250g) were used.
Tumours
Two tumours syngeneic for the hooded Lister rat were used.
These were the MC28 sarcoma used for the majority of the
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experiments, and the OES5 breast carcinoma. MC28 is a
methylcholanthrene-induced sarcoma and OES5 is an
oestrogen-induced breast carcinoma (Senior et al., 1985).
Both tumours were maintained by subcutaneous passage, the
MC28 every 14-21 days and the OES5 every 21-28 days.
Growth of OES5 is oestrogen dependent and so all animals
used with this tumour were females given oestrogen
implants. The implant was made by heating and fusing
together 80% Oestrone Gold Label (Aldrich Chemical Co.)
and 20% cholesterol (Aldrich Chemical Co.) in a crucible.
Preparation of cell suspensions
Tumours were removed from the flanks of passage animals,
chopped finely with scissors, washed in Hank's balanced salt
solution (Hank's BSS; Gibco) and then mechanically and
enzymatically disaggregated using a mixture of protease
0.5mgml- (Sigma No. P5647) and deoxyribonuclease
0.005mgml-1 (Sigma No. D4638) in Hank's BSS and a
magnetic stirrer for 45min. After allowing large lumps to
settle, the cell rich supernatant was pipetted off, spun down
and washed twice with Hank's BSS. Viability counts were
performed using trypan blue exclusion (Tennant, 1964) and
dilutions were adjusted to give 105 viable cells in 0.2ml.
Radiolabelling of tumour cells
OES5 cells could not be cultured and so no labelling
experiments were performed with this tumour. MC28 cells
were cultured in Dulbecco's Modified Eagle's Medium
(DMEM; Gibco) plus 20% foetal calf serum (Gibco),
10,000 Uml-1 penicillin and 10mgml-1 streptomycin
(Gibco) and nystatin 100Uml-1 (Sigma). Cells were sus-
pended to give a final concentration of 4x 106 viable cells
per 5ml culture medium. Six 25cm2 tissue culture flasks
(NUNC) each received 5ml of the suspension. Incubation
was performed at 37°C in 5% CO2 in humidified air. After
24h the medium was changed and 5pCi 51251-iodo-2-deox-
yuridine (Amersham International plc) was added to each
flask together with 5jUM 5-fluoro-2-deoxyuridine (Sigma) to
increase the incorporation of 5125I-iodo-2-deoxyuridine.
After a further 24h the cells were removed by replacing the
medium with Hank's BSS containing the mixture of protease
and deoxyribonuclease. After 15min, when the cells had
detached, the suspension was washed twice in Hank's BSS
and viability assessed using trypan blue exclusion. Dilution
was adjusted to give 105 viable cells in 0.2ml. In order to
assess radiolabelling, fixed cytospin preparations were auto-
radiographed using Ilford K2 emulsion and developed after
5 days using Ilford Contrast FF developer and Ilford
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Hypam fixer. Preparations were counterstained with Meyer's
Haemalum. This demonstrated that 70% of tumour cells
were labelled.
Colonic anastomoses
Under ether anaesthesia, the anterior abdominal wall was
shaved and the abdomen opened through a midline incision.
The left colon was delivered and transected with scissors,
taking care not to injure the mesenteric arterial arcade. Any
faeces in the immediate vicinity were removed but no formal
attempt was made to prepare the bowel, no antibiotics were
used and no dietary restrictions were imposed either pre or
post operatively. The bowel was anastomosed using one
layer of interrupted 6/0 silk sutures (Ethicon). The abdomen
was then closed and the animals allowed to recover.
Ileal anastomoses
In addition to the colonic anastomosis, some animals also
had an ileal anastomosis performed. The ileum was divided
2cm proximal to the ileocaecal valve and anastomosed with
one layer of interrupted 6/0 silk sutures.
Tumour cell injections
Under ether anaesthesia, the right internal carotid artery was
exposed, isolated between ligatures and opened. A 0.6mm
outside diameter polythene cannula (Boro Labs) was passed
proximally into the left ventricle. The correct position of the
cannula was confirmed by noting the resistance of the aortic
valve and the double wave form transmitted to the cannula.
Cells (105) in 0.2ml Hank's BSS were injected and flushed
in with saline. The cannula was then removed, the carotid
artery tied off and the skin closed. The animal was then
allowed to recover.
Relative timing of injection to anastomosis
The day of the tumour cell injection was regarded as day 0.
Colonic anastomoses were performed at intervals from day
-14 to day +4 with respect to the tumour cell injection.
Ileal anastomoses were performed on day -5 only.
Post mortem examinations
Animals were killed under ether anaesthesia on day +16
after tumour injection. The abdomen was opened and 1.5cm
of colon bearing the anastomosis was removed together with
an equal length of normal large bowel lying immediately
proximally. Where appropriate, 1.5cm of ileum bearing the
anastomosis was also removed. Specimens were opened,
mounted on blotting card and fixed in 10% formalin.
Longitudinal paraffin sections were made (3-5 for the anas-
tomosis and 2-4 for the normal bowel), stained with haema-
toxalin and eosin and examined for tumour.
Radiolabelled cell injections
On day -5, a left colonic anastomosis was performed in two
groups of 9 animals each. Each group received a separately
prepared and labelled tumour cell injection. On day 0, 105
radiolabelled MC28 cells were injected into the left ventricle
and the animal killed 5min later by injecting 20mg pento-
barbitone through the carotid cannula. The 1.5cm of colon
bearing the anastomosis and the adjacent 1.5cm of proximal
normal bowel were removed. These specimens plus a sample
of 105 cells were counted in a standard Wallac Decem series
automatic well gamma-counter within 12h of killing. No
labelled cell injections were performed in animals with ileal
anastomoses.
Autoradiographs of colonic anastomoses
Segments of bowel bearing an anastomosis were fixed in
10% formalin prior to gamma counting. After counting, the
specimens were opened and paraffin embedded histological
sections were made. These were then autoradiographed using
Ilford K2 emulsion and developed after 5 days using Ilford
Contrast FF developer and Ilford Hypam fixer. Specimens




Colonic anastomoses were performed prior to intracardiac
injection of 105 MC28 sarcoma cells on day -14 (n=10),
day -8 (n=10), day -7 (n=9), day -5 (n= 17), day -4
(n=9), day -2 (n= 14), day -1 (n=9), 2h prior (n= 15);
and after tumour injection at 1 h (n=8), on day +1 (n=10),
and on day +4 (n=5). Tumour growth occurred only at
anastomoses (Figure 1) and no tumour growth occurred in
normal bowel in any animal in this series. Figure 2 shows
the percentage of animals in each timing group bearing
tumour at the anastomosis. Tumour growth occurred at the
anastomotic site if anastomosis preceded tumour injection
but no tumour growth occurred if surgery was performed
after tumour injection. Maximum enhancement of tumour
growth occurred at days -5 to -7, i.e., when the healing
process had been in progress between 5 and 7 days. When
the anastomosis preceded the tumour injection by 14 days,
the enhancing effect of surgical trauma was mostly over. A
small enhancement of tumour growth occurred if injection
was performed within 2h of anastomosis.
Injection of 105 OES5 carcinoma cells 5 days after anasto-
mosis resulted in tumour growth and the anastomosis in 2 of
the 5 animals injected but not in normal bowel. No other
timing was investigated with this tumour.
In 4 animals, both ileal and colonic anastomoses were
performed 5 days prior to injection of 105 MC28 cells.
Tumour grew at all ileal anastomoses, and in greater quan-
tity macroscopically than at the colonic anastomoses. No




Figure 1 (a) Descending colon anastomosis with deposit of
MC28 sarcoma (arrowed); (b) Photomicrograph of deposit of
MC28 sarcoma at a colonic anastomosis (bar, 200jim).566 D. SKIPPER et al.
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Figure 2 Effect of timing of surgery on growth of MC28 sarcoma at colonic anastomoses. Day -14 versus day -8: x2 =7.5,
P<0.01; Day -8 to day -2: n.s.; Day -2 versus day -1: X2=6.3, P<0.02; Day -1 versus -2h: n.s.; Day -2 versus -2h:
x2-=4.14, P<0.05; -2h versus + I h: n.s.; Day -1 plus -2h versus + I h plus day + 1: X2 =4.26, P<0.05.
Radiolabelled cell injections
Two groups of 9 animals each were injected with 105
labelled MC28 sarcoma cells in two separate experiments.
Radiolabelling of cells in the first experiment was greater by
a factor of four compared to the second experiment. There
were variations in the counts per minute between the anasto-
moses of different animals and also the normal bowel
between different animals (Tables I and II). The geometric
means of the ratios of counts in anastomoses to normal
bowel were calculated for experiment 1 and experiment 2,
along with the 95% confidence intervals. There was approxi-
mately a 1.5-1.6 -times greater trapping of cells in the
anastomosis compared to the normal colon. As unity falls
between the 95% confidence intervals for both experiments,
this difference in trapping does not reach formal statistical
significance. However, with the good agreement between the
geometric mean ratio for both experiments and the fact that
unity is only just within the 95% confidence intervals, it may
well be that the difference in trapping in the anastomosis is a
real phenomenon.
In the first injection series (Table I), 105 cells resulted in
an estimated 92 cells arresting in 1.5 cm of normal colon and
141 cells arresting in the 1.5cm of colon bearing the
anastomosis. In the second series (Table II), 105 cells gave
an estimated 72 cells in 1.5cm of normal colon and 118 cells
trapping in the 1.5cm bearing the anastomosis. Figures from
both series agree well, and, taking an average of both series,
we calculate that from 105 cells injected, 82 cells trap in
1.5cm of normal colon and 130 in the 1.5cm bearing the
anastomosis. These 130 cells trapped at the anastomosis lead
to an average of three tumour nodules per anastomosis, i.e.,
there is a chance of 1:43 that a cell arriving at an anasto-
mosis will lead to a deposit.
Approximately 82 cells arrive in 1.5cm of normal colon,
i.e., - 0.8 x 103 cells or 0.8% of the total injected arrive in
the entire 15 cm of large bowel. This is of the same order as
results reported by Murphy et al. (1986) who found 1.7% of
injected MC28 sarcoma cells trapping in the colon. No
tumours are induced in normal colon. Therefore, in normal
colon, a trapped cell has a less than 1:0.8 x103 chance of
forming a deposit. This value is in fact a considerable
overestimate. Murphy et al. (1986) showed that even after
intracardiac injection of 5 x 106 cancer cells, calculated to
result in the trapping of 4 x 104 cancer cells in the colon, no
deposits arose. Accordingly, the probability of an MC28
sarcoma cell producing a metastasis in normal colon is less
than 1:4 x 104. The autoradiographs of the histological
sections of anastomoses after intracardiac injection of
labelled tumour cells did not demonstrate any grouping or
re-distribution of tumour cells in the region of the healing
anastomosis.
Discussion
Jones & Rous (1914) demonstrated that injuring the mouse
peritoneum with either Kieslguhr (to give a generalised
injury) or with glass rods (to give a localised injury)
enhanced growth of intraperitoneally injected tumour cells,
the enhancement being restricted to the area of injury in the
case of the glass rods. Other workers have demonstrated
limb trauma (Fisher et al., 1967), hepatic trauma (Fisher &
Fisher, 1965), and splenic trauma (Alexander & Altemeier,
1964) to enhance development of metastases in these organs
from bloodborne tumour cells. The normal colon and ileum
are refractory to growth of bloodborne tumour cells used in
this study (Murphy et al., 1986) and the colon and ileum are
clinically very rare sites for secondary deposits from tumours
elsewhere in the body. However, Alexander & Altemeier
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Table I Arrest of radiolabelled tumour cells: Experiment I
Normal bowel Anastomosis
Animal (1.5cm) (1.5cm) Ratio
number cpm cpm anastomosis/normal
1 156 315 2.02
2 362 410 1.13
3 183 191 1.04
4 20 158 7.90
5 229 197 0.86
6 2,031 905 0.45
7 246 391 1.59
8 43 72 1.67
9 243 563 2.32




of cells trapped 92 141
105 cells gave 203,536cpm, i.e. 1 cell gave 2cpm. Each sample was counted for 10min and
the background count of 43 min- was automatically subtracted.
Table II Arrest of radiolabelled tumour cells: Experiment 2
Normal bowel Anastomosis
Animal (1.5cm) (1.5cm) Ratio
number cpm cpm anastomosis/normal
1 8 38 4.75
2 18 38 2.11
3 42 41 0.98
4 173 95 0.55
5 40 139 3.48
6 58 81 1.40
7 36 51 1.42
8 39 38 0.97
9 33 73 2.21




of cells trapped 72 118
105 cells gave 49,334cpm, i.e., 2 cells gave 1 cpm. Each sample was counted for 10min
and the background count of 41 minm- was automatically subtracted.
aortic injection of V2 carcinoma cells in the rabbit, and
handling the bowel increased the number of animals with
deposits. No previous reports exist of the effect of surgical
transection and anastomosis on enhancing tumour growth in
large or small bowel. Cohn (1967) showed that Brown
Pearce tumour cells introduced into the lumen of the rabbit
bowel could implant on a colonic suture line. However, this
gives little indication of the enhancement of tumour growth
caused by trauma to the colon as the presence of the colonic
suture line may merely allow large numbers of cells to gain
access to the tissues rather than per se enhance tumour
growth.
From the results of this study it is clear that surgical
trauma enhances tumour growth from bloodborne cancer
cells in large bowel when the trauma precedes the tumour
injection. Maximum enhancement appears to occur when the
healing process has progressed between 2 to 8 days with a
peak between 5 and 7 days. A smaller peak occurs if cells
reach the anastomosis within 2h of its formation. A previous
study (Alexander & Altemeier, 1964), utilising chemical
trauma to the spleen, showed a maximum enhancement
when trauma preceded tumour injection by 2 to 5 days, the
effect then subsiding but still being present up to 37 days. In
the present study, enhancement is largely over when the
trauma precedes the tumour injection by 14 days. It is
noteworthy that transecting the bowel after the cells have
reached the tissue does not cause detectable enhancement of
tumour growth, even though tumour cells are known to
remain viable for up to 24h after trapping in tissues
(Murphy et al., 1988). Enhanced tumour growth at a healing
colonic anastomosis is not restricted to one tumour (MC28)
as the OES5 carcinoma also grows at colonic anastomoses.
Tumour growth is also enhanced by ileal anastomosis,
although the effect of timing on enhancement has not been
studied.
Fisher et al. (1967) showed that trauma to a hind limb
increased the trapping of arterially injected tumour cells by
1.9-3 times for mechanical trauma, 3.6-9.8 times for chemi-
cal trauma and 1.6-2.5 times for surgical incision and suture.
The figures of Fisher et al. (1967) for increased cell trapping
after surgery agree well with the present study where cell
trapping was increased by 1.5-1.6 times in the 1.5cm of
colon bearing the anastomosis, compared to an equal length
of normal colon. However, a cell arriving at the anastomosis
stands a 1:43 chance of forming a deposit whereas for a cell
arriving in normal colon the chance is less than 1:4 x 104.
There is approximately a 1,000 fold increase in the soil effect
in anastomosed colon compared to nop operated bowel. To
express a 'soil effect' numerically as a probability that a
single cell will cause a deposit requires that following
intracardiac injection, the cells are distributed singly within
the tissues. This was shown to be the case for normal tissue568 D. SKIPPER et al.
by Murphy et al. (1986; 1988) who found that following
intracardiac injection of single cell suspensions, the cells
distributed in the organs singly and randomly. Individual
cells were far apart and there was no possibility that the
tumour formed as the concerted action of several cancer
cells. We have no direct evidence of the distribution of
arrested cells in the 1.5cm of anastomosed colon. However,
as cell trapping is increased by only 1.5-1.6 times in the
anastomosed segment, one would need to postulate cells
being directed away from the normal areas within that
1.5cm to the actual healing area. Also, if a change in
haemodynamics and new vessel formation is leading to a re-
distribution of cells, it is unlikely that this effect would
persist throughout the entire period of tumour growth
enhancement, i.e., from within 2h after the surgery through
to 14 days after the surgery. The haemodynamics and the
amount of new vessel formation is very different between
days 2 and 8 of the healing process, which is a period when
enhancement of tumour growth is maximal. Lastly, auto-
radiographs of histological sections of the anastomoses did
not demonstrate any grouping of tumour cells at the anasto-
motic line, although total numbers of cells arrested would
have been small and hence difficult to detect unless grouping
at the anastomosis had been particularly marked. We there-
fore feel that the observed enhancement of tumour growth is
due to the influence of the healing process.
The implications of these observations are twofold. Firstly
this method provides a model for studying the effect of the
healing process on metastatic growth. The advantages of this
model are that no tumour deposition occurs unless the bowel
is traumatised, eliminating any background; and that the
trauma is easily and consistently reproduced. Secondly this
enhancement of tumour growth in the healing colonic anas-
tomosis may have importance in local recurrence of colorec-
tal cancer. Arterial delivery of experimental tumour cells to a
colonic anastomosis is not a model for local recurrence of a
human cancer. Rather, it demonstrates that the healing
process enhances tumour growth and indicates the order of
magnitude of this enhancement. Although enhancement is
most marked when healing has progressed between 2 and 8
days, there is still enhancement of tumour growth in colonic
anastomoses in the first few hours following surgery, the
time when cells spilled during surgery would encounter the
surrounding healing tissues. Spillage of exfoliated malignant
cells from the lumen of the bowel is held to be one cause of
local recurrence (Umpleby et al., 1984; Skipper et al., 1987)
and viable cells spilled into this enhanced environment for
tumour growth may be more likely to implant and form a
recurrence.
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